ATE194603T1 - Ein verfahren zur herstellung von tetrazolyl- verbindungen - Google Patents

Ein verfahren zur herstellung von tetrazolyl- verbindungen

Info

Publication number
ATE194603T1
ATE194603T1 AT95101055T AT95101055T ATE194603T1 AT E194603 T1 ATE194603 T1 AT E194603T1 AT 95101055 T AT95101055 T AT 95101055T AT 95101055 T AT95101055 T AT 95101055T AT E194603 T1 ATE194603 T1 AT E194603T1
Authority
AT
Austria
Prior art keywords
producing
tetrazolyl compounds
tetrazolyl compound
tetrazolyl
compounds
Prior art date
Application number
AT95101055T
Other languages
English (en)
Inventor
Yasushi Shida
Kokichi Yoshida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE194603T1 publication Critical patent/ATE194603T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95101055T 1994-01-28 1995-01-26 Ein verfahren zur herstellung von tetrazolyl- verbindungen ATE194603T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP823394 1994-01-28

Publications (1)

Publication Number Publication Date
ATE194603T1 true ATE194603T1 (de) 2000-07-15

Family

ID=11687442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95101055T ATE194603T1 (de) 1994-01-28 1995-01-26 Ein verfahren zur herstellung von tetrazolyl- verbindungen

Country Status (9)

Country Link
US (2) US5578733A (de)
EP (1) EP0668272B1 (de)
AT (1) ATE194603T1 (de)
CA (1) CA2141175C (de)
DE (1) DE69517832T2 (de)
DK (1) DK0668272T3 (de)
ES (1) ES2147798T3 (de)
GR (1) GR3034464T3 (de)
PT (1) PT668272E (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043709A1 (fr) 2000-12-01 2002-06-06 Takeda Chemical Industries, Ltd. Procede de production d'une preparation contenant une substance bioactive
EP1444988A4 (de) 2001-11-13 2007-04-25 Takeda Pharmaceutical Krebsmittel
EP1482896A4 (de) * 2002-03-01 2005-11-23 Merck & Co Inc Aminoalkylphosphonate und verwandte verbindungen als edg-rezeptor-agonisten
DE602004013405T2 (de) * 2003-03-17 2009-05-07 Teva Pharmaceutical Industries Ltd. Polymorphe formen von valsartan
WO2004085426A1 (en) * 2003-03-27 2004-10-07 Hetero Drugs Limited Novel crystalline forms of candesartan cilexetil
WO2004094391A2 (en) 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Process for the preparation of valsartan and intermediates thereof
CZ297016B6 (cs) * 2003-08-27 2006-08-16 Zentiva, A.S. Zpusob odstranování trifenylmethanové chránicí skupiny z 1-trityl-5-(4'-subst. aminomethyl-1,1' -bifenyl-2-yl)-1H-tetrazolu a zpusob výroby draselné soli losartanu, irbesartanu a valsartanu s jeho pouzitím
ES2284068T3 (es) * 2003-10-16 2007-11-01 Teva Pharmaceutical Industries Limited Preparacion de candesartan cilexetilo.
WO2005051928A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Process for production of tetrazolyl compounds
CA2555294A1 (en) * 2004-02-11 2005-08-25 Marina Yu Etinger Candesartan cilexetil polymorphs
MXPA06012702A (es) * 2004-05-05 2007-04-02 Teva Pharma Preparacion de candesartan cilexetil de alta pureza.
WO2005123720A1 (en) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Fine particles of the angiotensin ii antagonist candesartan cilexetil and process for production thereof
EP1655298A1 (de) * 2004-11-03 2006-05-10 LEK Pharmaceuticals d.d. Krystalline Polymorpheme Formen von Candesartan Cilexetil
WO2006050922A1 (en) * 2004-11-11 2006-05-18 Lek Pharmaceuticals D.D. Process for the synthesis of tetrazoles
KR20070088783A (ko) * 2005-01-14 2007-08-29 테바 파마슈티컬 인더스트리즈 리미티드 조 칸데사르탄 실렉세틸의 제조
KR100978592B1 (ko) * 2005-05-10 2010-08-27 테바 파마슈티컬 인더스트리즈 리미티드 안정한 미세 분말 칸데사탄 실렉세틸 및 이것의 제조 방법
WO2007074399A2 (en) 2005-06-06 2007-07-05 Medichem, S.A. Process for the preparation of tetrazolyl compounds
EP1816131A1 (de) * 2006-02-06 2007-08-08 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur Herstellung von Olmesartan Medoxomil
CA2616466A1 (en) 2005-07-29 2007-02-15 Krka Process for the preparation of olmesartan medoxomil
SI22127A (sl) 2005-10-07 2007-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo kandesartan cileksetila
CZ299265B6 (cs) * 2005-10-20 2008-05-28 Zentiva, A. S. Zpusob výroby 1-(cyklohexyloxykarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)bifenyl-4-yl]methyl]benzimidazol-7-karboxylátu (candesartan cilexetilu)
ITTO20060560A1 (it) * 2006-07-27 2008-01-28 S I M S S R L Composti intermedi per la preparazione di antagonisti dell¿angiotensina ii
EP2049510A1 (de) * 2006-07-28 2009-04-22 Krka Tovarna Zdravil, D.D., Novo Mesto Verfahren zur herstellung von candesartandilexetil form i
EP2170868A1 (de) * 2007-07-11 2010-04-07 Alembic Limited Verbessertes verfahren zur herstellung von candesartancilexetil
JP2012527446A (ja) 2009-05-20 2012-11-08 ランバクシー ラボラトリーズ リミテッド オルメサルタン・メドキソミルの調製方法
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
KR101251741B1 (ko) 2010-12-16 2013-04-05 동화약품주식회사 칸데사르탄실렉세틸의 개선된 제조방법
CN103396408A (zh) * 2013-08-13 2013-11-20 河南华商药业有限公司 坎地沙坦酯中杂质b的制备方法
CN109627234A (zh) * 2019-01-30 2019-04-16 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法
CN109776503A (zh) * 2019-01-30 2019-05-21 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法
CN109851612A (zh) * 2019-01-30 2019-06-07 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB9017480D0 (en) * 1990-08-09 1990-09-26 Ici Plc Chemical process
TW209213B (de) * 1991-08-21 1993-07-11 Yamanouchi Pharma Co Ltd
EP0531874A1 (de) * 1991-09-10 1993-03-17 Tanabe Seiyaku Co., Ltd. Imidazopyridin-Derivate und Verfahren für ihre Herstellung
DE4132632A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Substituierte imidazolyl-propensaeurederivate
EP0550313A1 (de) * 1991-12-30 1993-07-07 Synthelabo 2-(Tetranol-5-yl)-(1,1'-Biphenyl)derivate, ihre Herstellung und Anwendung als Zwischenverbindungen
DE4212748A1 (de) * 1992-04-16 1993-10-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
DE69517832T2 (de) 2000-11-09
CA2141175C (en) 2006-12-12
DK0668272T3 (da) 2000-09-18
US5578733A (en) 1996-11-26
EP0668272A2 (de) 1995-08-23
EP0668272A3 (de) 1995-08-30
EP0668272B1 (de) 2000-07-12
US5763619A (en) 1998-06-09
PT668272E (pt) 2000-10-31
ES2147798T3 (es) 2000-10-01
CA2141175A1 (en) 1995-07-29
DE69517832D1 (de) 2000-08-17
GR3034464T3 (en) 2000-12-29

Similar Documents

Publication Publication Date Title
DE69517832D1 (de) Ein Verfahren zur Herstellung von Tetrazolyl-Verbindungen
ATE174903T1 (de) Neues verfahren zur herstellung von 7- (substituierten)-9-((substistuierter
DE69400496D1 (de) Verfahren zur Herstellung von Alkylpolyglucosiden
ATE137488T1 (de) Verfahren zur herstellung von reiner hydroxyessigsäure
HUT77178A (hu) Szubsztituált 3-amino-benzonitrilek, eljárás előállításukra, és eljárás benzatiadiazol-7-karboxilsav előállítására
HUT37141A (en) Process for production of substituted 5,11-dihydro-6h-dibenz /b,e/ azepin-6-ons
ID27149A (id) Proses pembuatan asam hidroksimetiltiobutirat
ATE41154T1 (de) Verfahren zur herstellung alkanphosphoniger saeuren.
ATE152091T1 (de) Verfahren zur herstellung von funktionalisierten perfluorpolyoxyalkylenen
ATE187711T1 (de) Verfahren zur reinigung von o-phthaldialdehyd
ATE253030T1 (de) Verfahren zur herstellung von 1,1,4,4- tetramethoxybuten-2
ATE119154T1 (de) Verfahren zur herstellung von 2-chlor-5- chlormethyl-pyridin.
ATE139765T1 (de) Verfahren zur herstellung von halogenanthranilsäuren
ATE207908T1 (de) Verfahren zur herstellung von 2-alkoxy-6- (trifluormethyl)-pyrimidin-4-ol
DE69532576D1 (de) Verfahren zur herstellung von 2-(tetrazol-5-yl)-4-oxo-4h-benzopyranen
ATE240937T1 (de) Gamma-oxohomophenylalanin derivate und ein verfahren zur herstellung von homophenylalanin derivaten durch reduktion derselben
ATE236909T1 (de) Verfahren zur herstellung von phosphorohalidaten
DE60028998D1 (de) Verfahren zur herstellung einer benzylamin-verbindung
ATE163181T1 (de) Verfahren zur herstellung von 2- cyaniminothiazolidin
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate
DE59502722D1 (de) Verfahren und Zwischenprodukte zur Herstellung von 5-Oxaspiro [2.4] heptan-6-on
ATE228495T1 (de) Verfahren zur herstellung von 3-hydroxy-2- methylbenzoesäure
ATE231125T1 (de) Einfaches verfahren zur herstellung von hochwertigem captropril
DE69720432D1 (de) Verfahren zur herstellung von 2-hydroxynaphtalin-3,6-dicarbonsaure
ATE147064T1 (de) Verfahren zur herstellung von endo/exo-8-n,n- dialkylaminoexo-tricyclo(5.2.1.0 2,6) decan

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification